Tag: type 2 diabetes management

Glucagon-like peptide-1 (GLP-1) receptor agonists—widely prescribed for type 2 diabetes and obesity—may carry a small but clinically important safety signal, ...

A groundbreaking retrospective chart review, recently published in the prestigious Journal of Clinical Medicine, reveals compelling real-world evidence that deprescribing ...

Recent research has brought to light the promising therapeutic potentials of an extract derived from Eryngium caucasicum, specifically in the ...

In a groundbreaking study poised to reshape the landscape of type 2 diabetes management, researchers have put current glucose-lowering medications ...

In the rapidly evolving field of diabetes research, a recent study offers promising insights into multi-target antidiabetic therapies, specifically focusing ...

In recent years, there has been a significant amount of scientific inquiry into the management of diabetes mellitus type 2, ...

Recent research has highlighted a significant relationship between the daily dosage of dipeptidyl peptidase-4 (DPP-4) inhibitors and the variations in ...

A recent study conducted by Alemu, Narasimhan, and Alexander sheds light on the significant impact of semaglutide in managing kidney ...

In an age where artificial intelligence and machine learning are increasingly making significant strides in healthcare, a recent study published ...

The recent systematic review and meta-analysis conducted by Zhou et al. has unveiled significant findings regarding the effects of Glucagon-Like ...